• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经节苷脂代谢与帕金森病

Ganglioside Metabolism and Parkinson's Disease.

作者信息

Forsayeth John, Hadaczek Piotr

机构信息

Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, United States.

出版信息

Front Neurosci. 2018 Feb 5;12:45. doi: 10.3389/fnins.2018.00045. eCollection 2018.

DOI:10.3389/fnins.2018.00045
PMID:29459819
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5807391/
Abstract

Here we advance the hypothesis that Parkinson's disease (PD) is fundamentally a failure of trophic support for specific classes of neurons, primarily catecholaminergic. Evidence from our laboratory provides a framework into which a broad array of findings from many quarters can be integrated into a general theory that offers testable hypotheses to new and established investigators. Mice deficient in the ability to synthesize series-a gangliosides, specifically GM1 ganglioside, develop parkinsonism. We found that this seems to be due to a failure in signaling efficiency by the important catecholaminergic growth factor, GDNF. Interestingly, these mice accumulate alpha-synuclein in nigral neurons. Striatal over-expression of GDNF eliminates these aggregates and also restores normal motor function. These findings bring into question common beliefs about alpha-synuclein pathology and may help us to reinterpret other experimental findings in a new light. The purpose of this article is to provoke new thinking about PD and hopefully encourage younger scientists to explore some of the ideas presented below.

摘要

在此,我们提出一个假说:帕金森病(PD)本质上是特定类型神经元(主要是儿茶酚胺能神经元)营养支持的失败。我们实验室的证据提供了一个框架,许多方面的广泛研究结果都可以整合到一个通用理论中,该理论为新老研究人员提供了可检验的假设。缺乏合成a系列神经节苷脂(特别是GM1神经节苷脂)能力的小鼠会出现帕金森综合征。我们发现,这似乎是由于重要的儿茶酚胺能生长因子GDNF的信号传导效率低下所致。有趣的是,这些小鼠在黑质神经元中积累α-突触核蛋白。纹状体内GDNF的过表达消除了这些聚集体,并恢复了正常的运动功能。这些发现对关于α-突触核蛋白病理学的普遍观点提出了质疑,并可能帮助我们以新的视角重新解释其他实验结果。本文的目的是激发对帕金森病的新思考,并有望鼓励年轻科学家探索以下提出的一些观点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d94/5807391/28f7d37a1176/fnins-12-00045-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d94/5807391/6b67b2e4c611/fnins-12-00045-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d94/5807391/b108eb7012f4/fnins-12-00045-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d94/5807391/4c99fdfa150d/fnins-12-00045-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d94/5807391/28f7d37a1176/fnins-12-00045-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d94/5807391/6b67b2e4c611/fnins-12-00045-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d94/5807391/b108eb7012f4/fnins-12-00045-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d94/5807391/4c99fdfa150d/fnins-12-00045-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d94/5807391/28f7d37a1176/fnins-12-00045-g0004.jpg

相似文献

1
Ganglioside Metabolism and Parkinson's Disease.神经节苷脂代谢与帕金森病
Front Neurosci. 2018 Feb 5;12:45. doi: 10.3389/fnins.2018.00045. eCollection 2018.
2
GDNF signaling implemented by GM1 ganglioside; failure in Parkinson's disease and GM1-deficient murine model.由GM1神经节苷脂实现的胶质细胞源性神经营养因子信号传导;在帕金森病和GM1缺陷小鼠模型中的失败。
Exp Neurol. 2015 Jan;263:177-89. doi: 10.1016/j.expneurol.2014.10.010. Epub 2014 Oct 23.
3
Gangliosides, α-Synuclein, and Parkinson's Disease.神经节苷脂、α-突触核蛋白与帕金森病。
Prog Mol Biol Transl Sci. 2018;156:435-454. doi: 10.1016/bs.pmbts.2017.12.009. Epub 2018 Feb 24.
4
GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease.GDNF 未能在帕金森病的大鼠 α-突触核蛋白模型中发挥神经保护作用。
Brain. 2011 Aug;134(Pt 8):2302-11. doi: 10.1093/brain/awr149. Epub 2011 Jun 28.
5
The relationship between depletion of brain GM1 ganglioside and Parkinson's disease.脑 GM1 神经节苷脂耗竭与帕金森病的关系。
FEBS Open Bio. 2023 Sep;13(9):1548-1557. doi: 10.1002/2211-5463.13554. Epub 2023 Feb 5.
6
Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.替米沙坦通过调节 C57BL/6J 小鼠中α-突触核蛋白和神经营养因子(BDNF 和 GDNF)的表达来减轻 MPTP 诱导的多巴胺能变性和运动功能障碍。
Neuropharmacology. 2013 Oct;73:98-110. doi: 10.1016/j.neuropharm.2013.05.025. Epub 2013 Jun 6.
7
Lentiviral nigral delivery of GDNF does not prevent neurodegeneration in a genetic rat model of Parkinson's disease.在帕金森病基因大鼠模型中,通过慢病毒将胶质细胞源性神经营养因子(GDNF)递送至黑质并不能预防神经退行性变。
Neurobiol Dis. 2004 Nov;17(2):283-9. doi: 10.1016/j.nbd.2004.06.008.
8
Mice deficient in GM1 manifest both motor and non-motor symptoms of Parkinson's disease; successful treatment with synthetic GM1 ganglioside.GM1 缺乏症小鼠表现出帕金森病的运动和非运动症状;用合成 GM1 神经节苷脂进行成功治疗。
Exp Neurol. 2020 Jul;329:113284. doi: 10.1016/j.expneurol.2020.113284. Epub 2020 Mar 9.
9
GM1 ganglioside enhances Ret signaling in striatum.GM1神经节苷脂增强纹状体中的Ret信号传导。
J Neurochem. 2014 Aug;130(4):541-54. doi: 10.1111/jnc.12760. Epub 2014 Jun 13.
10
Heredity in Parkinson's disease: new findings.帕金森病的遗传:新发现
Isr Med Assoc J. 2001 Jun;3(6):435-8.

引用本文的文献

1
Ganglioside lipids inhibit the aggregation of the Alzheimer's amyloid-β peptide.神经节苷脂抑制阿尔茨海默病β淀粉样肽的聚集。
RSC Chem Biol. 2025 Mar 13;6(5):809-822. doi: 10.1039/d4cb00189c. eCollection 2025 May 8.
2
Gangliosides and the Treatment of Neurodegenerative Diseases: A Long Italian Tradition.神经节苷脂与神经退行性疾病的治疗:悠久的意大利传统。
Biomedicines. 2022 Feb 2;10(2):363. doi: 10.3390/biomedicines10020363.
3
Novel insights on GM1 and Parkinson's disease: A critical review.GM1 与帕金森病的新见解:批判性回顾。

本文引用的文献

1
In vivo models of alpha-synuclein transmission and propagation.α-突触核蛋白传播和扩散的体内模型。
Cell Tissue Res. 2018 Jul;373(1):183-193. doi: 10.1007/s00441-017-2730-9. Epub 2017 Nov 29.
2
Glucosylsphingosine Promotes α-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease.葡糖神经鞘氨醇在突变型GBA相关帕金森病中促进α-突触核蛋白病变。
J Neurosci. 2017 Oct 4;37(40):9617-9631. doi: 10.1523/JNEUROSCI.1525-17.2017. Epub 2017 Aug 28.
3
Insights from mathematical modeling for convection-enhanced intraputamenal delivery of GDNF.
Glycoconj J. 2022 Feb;39(1):27-38. doi: 10.1007/s10719-021-10019-7. Epub 2022 Jan 22.
4
Gangliosides as Biomarkers of Human Brain Diseases: Trends in Discovery and Characterization by High-Performance Mass Spectrometry.神经节苷脂作为人类脑部疾病的生物标志物:高效质谱法在发现和鉴定方面的趋势。
Int J Mol Sci. 2022 Jan 8;23(2):693. doi: 10.3390/ijms23020693.
5
GM1 Oligosaccharide Crosses the Human Blood-Brain Barrier In Vitro by a Paracellular Route.GM1 寡糖通过细胞旁途径在体外穿过人血脑屏障。
Int J Mol Sci. 2020 Apr 19;21(8):2858. doi: 10.3390/ijms21082858.
6
GM1 Ganglioside Is A Key Factor in Maintaining the Mammalian Neuronal Functions Avoiding Neurodegeneration.神经节苷脂 GM1 是维持哺乳动物神经元功能、避免神经退行性变的关键因素。
Int J Mol Sci. 2020 Jan 29;21(3):868. doi: 10.3390/ijms21030868.
7
Self-Assembly in Ganglioside‒Phospholipid Systems: The Co-Existence of Vesicles, Micelles, and Discs.神经节苷脂-磷脂体系中的自组装:囊泡、胶束和盘的共存。
Int J Mol Sci. 2019 Dec 20;21(1):56. doi: 10.3390/ijms21010056.
8
Parkinson's disease recovery by GM1 oligosaccharide treatment in the B4galnt1 mouse model.GM1 寡糖治疗 B4galnt1 小鼠模型中的帕金森病恢复。
Sci Rep. 2019 Dec 18;9(1):19330. doi: 10.1038/s41598-019-55885-2.
9
Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson's disease.帕金森病中鞘脂类水解酶活性、底物堆积和神经节苷脂水平降低。
Mol Neurodegener. 2019 Nov 8;14(1):40. doi: 10.1186/s13024-019-0339-z.
10
The Neuroprotective Role of the GM1 Oligosaccharide, IINeu5Ac-Gg, in Neuroblastoma Cells.GM1 寡糖 IINeu5Ac-Gg 在神经母细胞瘤细胞中的神经保护作用。
Mol Neurobiol. 2019 Oct;56(10):6673-6702. doi: 10.1007/s12035-019-1556-8. Epub 2019 Mar 26.
数学模型对 GDNF 增强型内囊内递药的启示。
Med Biol Eng Comput. 2017 Dec;55(12):2069-2077. doi: 10.1007/s11517-017-1650-x. Epub 2017 May 11.
4
Constipation: an emerging risk factor for Parkinson's disease?便秘:帕金森病的一个新出现的风险因素?
Eur J Neurol. 2016 Nov;23(11):1606-1613. doi: 10.1111/ene.13082. Epub 2016 Jul 22.
5
Semisynthetic and in Vitro Phosphorylation of Alpha-Synuclein at Y39 Promotes Functional Partly Helical Membrane-Bound States Resembling Those Induced by PD Mutations.α-突触核蛋白在Y39位点的半合成及体外磷酸化促进了功能性部分螺旋膜结合状态,类似于由帕金森病突变诱导的状态。
ACS Chem Biol. 2016 Sep 16;11(9):2428-37. doi: 10.1021/acschembio.6b00539. Epub 2016 Jul 11.
6
Protein degradation in a LAMP-2-deficient B-lymphoblastoid cell line from a patient with Danon disease.来自一名丹侬病患者的LAMP-2缺陷型B淋巴母细胞系中的蛋白质降解
Biochim Biophys Acta. 2016 Aug;1862(8):1423-32. doi: 10.1016/j.bbadis.2016.04.014. Epub 2016 Apr 26.
7
Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation.导致帕金森病的α-突触核蛋白错义突变将天然四聚体转变为单体,作为疾病起始的一种机制。
Nat Commun. 2015 Jun 16;6:7314. doi: 10.1038/ncomms8314.
8
Visual Attention and Saccadic Oculomotor Control in Parkinson's Disease.帕金森病中的视觉注意力与眼球跳动性眼动控制
Eur Neurol. 2015;73(5-6):283-93. doi: 10.1159/000381335. Epub 2015 Apr 24.
9
Parkinson's disease and the skin.帕金森病与皮肤。
Pract Neurol. 2015 Aug;15(4):246-9. doi: 10.1136/practneurol-2015-001107. Epub 2015 Apr 10.
10
Imaging acetylcholinesterase density in peripheral organs in Parkinson's disease with 11C-donepezil PET.使用11C-多奈哌齐PET成像帕金森病外周器官中的乙酰胆碱酯酶密度。
Brain. 2015 Mar;138(Pt 3):653-63. doi: 10.1093/brain/awu369. Epub 2014 Dec 23.